Dierks Jeffrey (CIK 1821102) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-05). Recent activity: Buy HRMY (4,869 shares), Sell HRMY (4,369 shares), Sell HRMY (500 shares), Buy HRMY (13,125 shares), Sell HRMY (8,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 4,869 | $40,023 |
| 2025-03-05 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 4,369 | $142,473 |
| 2025-03-05 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 500 | $16,615 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 13,125 | $402,806 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 8,000 | $295,520 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 5,125 | $194,084 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 2,687 | $0 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 1,058 | $40,215 |
| 2025-01-28 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 1,629 | $61,935 |
| 2025-01-21 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 29,475 | $985,644 |
| 2025-01-21 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 29,475 | $1.1M |
| 2025-01-21 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 1,123 | $37,553 |
| 2025-01-21 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 1,123 | $44,920 |
| 2025-01-16 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 10,507 | $351,354 |
| 2025-01-16 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 10,507 | $388,864 |
| 2025-01-15 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Buy | 7,180 | $240,099 |
| 2025-01-15 | Harmony Biosciences Holdings, Inc. (HRMY) | CHIEF COMMERCIAL OFFICER | Sell | 7,180 | $265,947 |
Source: SEC Form 4 filings · as of 2025-03-05